Allergy

Biosimilars

Cardiology

Dermatology

Endocrinology

Family Medicine

Gastroenterology

Geriatrics

Hospital Medicine

Infectious Disease

Internal Medicine

Nephrology

Neurology

Obesity Management

Ophthalmology

Pain

Pediatrics

Psychiatry

Pulmonology

Rare Disease Report®

Rheumatology

Sleep

Surgery

Women's Health

News

Media

Medical World News

Podcasts

Shows

State Of Sciences - Presentations

Videos

Webinars

Multimedia Series

Insights

Medcast Podcasts

Medcast Videos

Peer Exchange

Peers & Perspectives

Conferences

Conference Coverage

Conference Listing

Partners

CME/CE

Resources

Interactive Tools

Live Events

Press Release

Publications

Subscribe

Connor Iapoce is an associate editor for 

 and joined the MJH Life Sciences team in April 2021. He graduated from The College of New Jersey with a degree in Journalism and Professional Writing. He enjoys listening to records, going to concerts, and playing with his cat Squish. You can reach him at 

Articles

An analysis of the Lifelines cohort revealed DED had a significant impact on work functioning, comparable to the impact of other chronic diseases considered function impairing. 

Dry Eye Disease Linked to Impaired Work Functioning 

Lana Pine is the editor of HCPLive Rheumatology. She is an experienced editor and technical writer with a demonstrated history of working in the banking and publishing industries. In her free time, she enjoys cooking, yoga, listening to podcasts, and drawing. She can be reached via email at LPine@mjhlifesciences.com.

Musculoskeletal ultrasound evaluated tophus size and double contour sign in lower extremity joints of patients with gout before and after initiating uric acid lowering therapy.



Significant Decreases in Tophus, Double Contour Sign Observed in Patients With Gout Receiving ULT

It wasn't the unavailability of varenicline, but the inaccessibility, that perpetuated the reduced prevalence of prescriptions. Investigators speculated that patient, clinician awareness and concerns related to nitrosamine were contributing factors.

Data Show 74.7% Reduction in Varenicline Use for Nicotine Dependence After Chantix Recall

Phase 2b findings suggest VEGF-C/D inhibition with 2.0 mg OPT-302 in combination with ranibizumab achieves superior vision gains compared to the current standard of care for nAMD. 

OPT-302 Combination Therapy Could Improve nAMD Visual Outcomes

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.

About Us

Advertise

Editorial

Contact Us

Do Not Sell My Information

Privacy

Terms & Conditions

HCPLive - Clinical news for connected physicians

Facebook

Twitter

LinkedIn

Spotlight

Biosimilars Spotlight

COVID-19

Qazi Corner

This Year In Medicine 2022

Clinical

ADHD

Arterial Disease

Diabetes

Geriatric Medicine

Video Series

News Network

Post Conference Perspectives

 Peers & Perspective page is a resource for sit-down video interviews between expert colleagues and peers on major topics in clinical practice and research.

1rem

Peers Perspectives

Advances in the Management of Hypercholesterolemia

Consequences of Hypercholesterolemia

Cardiovascular Disease Risk Factors

Socioeconomic Status and Hypercholesterolemia

Cardiovascular Disease in Younger Populations

Lifestyle Modifications to Manage Hypercholesterolemia

Hypercholesterolemia: Shared Decision-Making 

Selecting a Statin Therapy to Manage LDL-C

Managing Intolerance to Statin Therapy

PCSK9 Inhibitors and LDL-C Reduction 

Cardiovascular Outcomes: FOURIER and ODYSSEY

Lipoprotein(a) and PCSK9 Utilization

Real-World Experience With PCSK9 Inhibitors

Increasing Confidence in Prescribing PCSK9 Inhibitors

ACS: Early Intervention With PCSK9 Therapy

Optimal Management of Hypercholesterolemia